NCT07116993

Brief Summary

The study aims to compare the effectiveness of therapeutic ultrasound and infrared in managing hemarthrosis in patients with Hemophilia A, focusing on specific outcomes like joint pain, swelling, muscle atrophy, and range of motion.The main question to it is either one from both of the modalities are effective for hemophilia patients or not? comparison will be done to check the effectiveness of ultrasound and infrared on patients of both groups. participants will:

  1. 1.get the treatment according to their respective groups
  2. 2.Both groups were given 4 sessions for 4 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 30, 2024

Completed
10 months until next milestone

First Posted

Study publicly available on registry

August 12, 2025

Completed
Last Updated

August 12, 2025

Status Verified

August 1, 2025

Enrollment Period

29 days

First QC Date

October 30, 2024

Last Update Submit

August 4, 2025

Conditions

Keywords

hemophilia Aultrasoundinfraredjoint health

Outcome Measures

Primary Outcomes (3)

  • joint pain

    Joint Pain: Measured using the Numerical Pain Rating Scale (NPRS) to quantify changes in pain severity. 0 indicates no pain while 10 indicates severe pain

    3 weeks

  • ROM

    Range of Motion (ROM): Measured using a goniometer to assess improvements in flexion and extension angles, measured in degrees, in the joint.

    3 weeks

  • Swelling

    Assessed based on circumference measurements around knee, elbow and ankle joint using inelastic tape measure in centimeters around the affected joint to detect reductions in swelling.

    3 weeks

Study Arms (2)

ultrasound

EXPERIMENTAL

ultrasound group containing 15 participants who were given ultrasound therapy for 10 minutes along with the conventional physiotherapy.

Device: theraputic ultrasound

infrared radiation

EXPERIMENTAL

infrared radiation group containing 15 participants who were treated with infrared therapy for 10 minutes along with the conventional physiotherapy.

Device: infrared radiation

Interventions

Ultrasound is a mechanical sound wave with frequencies above human hearing, requiring a medium like air or tissue to travel, commonly used in imaging.

ultrasound

Infrared, in contrast, is electromagnetic radiation associated with heat, doesn't need a medium, and is used in applications like thermal imaging and remote controls.

infrared radiation

Eligibility Criteria

Sexmale(Gender-based eligibility)
Gender Eligibility Detailsmales with hemophilia A
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with hemophilia A (Eid \& Aly, 2015) .
  • Who had the Bleeding frequency of atleast once per week (Eid \& Aly, 2015).
  • Males with hemophilia A
  • Irrespective of their therapeutic regime administered by their hematologists (Donoso-Úbeda, Meroño-Gallut, López-Pina, \& Cuesta Barriuso, 2020) .

You may not qualify if:

  • Patients who had surgical procedures (Eid \& Aly, 2015) .
  • Patients who were suffering from co-morbidities along with Hemophilia A.
  • Patients who had any other disability/deformity.
  • Who were receiving other physiotherapy treatment (Donoso-Úbeda et al., 2020) .
  • Who failed to sign the informed consent (Donoso-Úbeda et al., 2020)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Danyal Ahmad

Sialkot, Punjab Province, 51010, Pakistan

Location

MeSH Terms

Conditions

Hemophilia A

Condition Hierarchy (Ancestors)

Blood Coagulation Disorders, InheritedBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesCoagulation Protein DisordersHemorrhagic DisordersGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
head supervior

Study Record Dates

First Submitted

October 30, 2024

First Posted

August 12, 2025

Study Start

March 1, 2024

Primary Completion

March 30, 2024

Study Completion

June 15, 2024

Last Updated

August 12, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations